A pilot study proposing an algorithm for pubertal induction in cerebral palsy.

Cerebral disability hormones hypogonadism puberty

Journal

Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900

Informations de publication

Date de publication:
20 Feb 2024
Historique:
received: 06 01 2024
accepted: 18 01 2024
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 19 2 2024
Statut: aheadofprint

Résumé

To explore delayed puberty in cerebral palsy (CP) and to test the acceptability of an interventional puberty induction algorithm. A two phase cohort study in children and adolescents diagnosed with CP who have delayed puberty. Phase 1: Retrospective review of clinical records and interviews with patients who have been treated with sex-steroids and Phase 2: Prospective interventional trial of pubertal induction with a proposed algorithm of transdermal testosterone (males) or oestrogen (females). Phase 1 examined experiences with sex-steroid treatment. Phase 2 collected data on height adjusted bone mineral density (BMAD), fractures, adverse effects, mobility and quality of life over two years during the induction. Phase 1, treatment was well tolerated in 11/20 treated with sex-steroids; phase 2, using the proposed induction algorithm, 7/10 treated reached Tanner stage 3 by nine months. One participant reached Tanner stage 5 in 24 months. Mean change in BMAD Z-scores was +0.27 % (SD 0.002) in those who could be scanned by dual-energy X-ray absorptiometry (DXA). Delayed puberty may be diagnosed late. Treatment was beneficial and well tolerated, suggesting all patients with severe pubertal delay or arrest should be considered for sex hormone supplementation.

Identifiants

pubmed: 38374118
pii: jpem-2024-0013
doi: 10.1515/jpem-2024-0013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 the author(s), published by De Gruyter, Berlin/Boston.

Références

Colver, A, Fairhurst, C, Pharoah, PO. Cerebral palsy. Lancet 2014;383:1240–9. https://doi.org/10.1016/s0140-6736(13)61835-8 .
doi: 10.1016/s0140-6736(13)61835-8
Cremer, N, Hurvitz, EA, Peterson, MD. Multimorbidity in middle-aged adults with cerebral palsy. Am J Med 2017;130:744 e749–15. https://doi.org/10.1016/j.amjmed.2016.11.044 .
doi: 10.1016/j.amjmed.2016.11.044
Trinh, A, Wong, P, Fahey, MC, Brown, J, Churchyard, A, Strauss, BJ, et al.. Musculoskeletal and endocrine health in adults with cerebral palsy: new opportunities for intervention. J Clin Endocrinol Metab 2016;101:1190–7. https://doi.org/10.1210/jc.2015-3888 .
doi: 10.1210/jc.2015-3888
Henderson, RC, Kairalla, J, Abbas, A, Stevenson, RD. Predicting low bone density in children and young adults with quadriplegic cerebral palsy. Dev Med Child Neurol 2004;46:416–9. https://doi.org/10.1017/s0012162204000672 .
doi: 10.1017/s0012162204000672
Houlihan, CM. Bone health in cerebral palsy: who’s at risk and what to do about it? J Pediatr Rehabil Med 2014;7:143–53. https://doi.org/10.3233/prm-140283 .
doi: 10.3233/prm-140283
Kuperminc, MN, Gurka, MJ, Houlihan, CM, Henderson, RC, Roemmich, JN, Rogol, AD, et al.. Puberty, statural growth, and growth hormone release in children with cerebral palsy. J Pediatr Rehabil Med 2009;2:131–41. https://doi.org/10.3233/prm-2009-0072 .
doi: 10.3233/prm-2009-0072
Robertson, CM, Morrish, DW, Wheler, GH, Grace, MG. Neonatal encephalopathy: an indicator of early sexual maturation in girls. Pediatr Neurol 1990;6:102–8. https://doi.org/10.1016/0887-8994(90)90042-y .
doi: 10.1016/0887-8994(90)90042-y
Bruzzi, P, Messina, MF, Bartoli, A, Predieri, B, Lucaccioni, L, Madeo, SF, et al.. Central precocious puberty and response to GnRHa therapy in children with cerebral palsy and moderate to severe motor impairment: data from a longitudinal, case-control, multicentre, Italian study. Int J Endocrinol 2017;2017:4807163. https://doi.org/10.1155/2017/4807163 .
doi: 10.1155/2017/4807163
Worley, G, Houlihan, CM, Herman-Giddens, ME, O’Donnell, M, Conaway, M, Stallings, VA, et al.. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 2002;110:897–902. https://doi.org/10.1542/peds.110.5.897 .
doi: 10.1542/peds.110.5.897
Uday, S, Shaw, N, Krone, R, Kirk, J. Hypopituitarism in children with cerebral palsy. Arch Disease Child Educ Pract Ed 2017;102:559–61. https://doi.org/10.1136/archdischild-2016-311012 .
doi: 10.1136/archdischild-2016-311012
Golden, NH, Lanzkowsky, L, Schebendach, J, Palestro, CJ, Jacobson, MS, Shenker, IR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002;15:135–43. https://doi.org/10.1016/s1083-3188(02)00145-6 .
doi: 10.1016/s1083-3188(02)00145-6
Strokosch, GR, Friedman, AJ, Wu, SC, Kamin, M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 2006;39:819–27. https://doi.org/10.1016/j.jadohealth.2006.09.010 .
doi: 10.1016/j.jadohealth.2006.09.010
Misra, M, Katzman, D, Miller, KK, Mendes, N, Snelgrove, D, Russell, M, et al.. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Min Res 2011;26:2430–8. https://doi.org/10.1002/jbmr.447 .
doi: 10.1002/jbmr.447
Henderson, RC, Gilbert, SR, Clement, ME, Abbas, A, Worley, G, Stevenson, RD. Altered skeletal maturation in moderate to severe cerebral palsy. Dev Med Child Neurol 2005;47:229–36. https://doi.org/10.1111/j.1469-8749.2005.tb01127.x .
doi: 10.1111/j.1469-8749.2005.tb01127.x
Pfeil, A, Haugeberg, G, Renz, DM, Reinhardt, L, Jung, C, Franz, M, et al.. Digital X-ray radiogrammetry and its sensitivity and specificity for the identification of rheumatoid arthritis-related cortical hand bone loss. J Bone Miner Metabol 2017;35:192–8. https://doi.org/10.1007/s00774-016-0741-3 .
doi: 10.1007/s00774-016-0741-3
Palisano, R, Rosenbaum, P, Walter, S, Russell, D, Wood, E, Galuppi, B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214–23. https://doi.org/10.1111/j.1469-8749.1997.tb07414.x .
doi: 10.1111/j.1469-8749.1997.tb07414.x
Cummings, SR, Ferrari, S, Eastell, R, Gilchrist, N, Jensen, JB, McClung, M, et al.. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Min Res 2018;33:190–8. https://doi.org/10.1002/jbmr.3337 .
doi: 10.1002/jbmr.3337
Anastasilakis, AD, Polyzos, SA, Makras, P, Aubry-Rozier, B, Kaouri, S, Lamy, O. Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Min Res 2017;32:1291–6. https://doi.org/10.1002/jbmr.3110 .
doi: 10.1002/jbmr.3110
McClung, MR, Wagman, RB, Miller, PD, Wang, A, Lewiecki, EM. Observations following discontinuation of long-term denosumab therapy. Osteoporos Int 2017;28:1723–32. https://doi.org/10.1007/s00198-017-3919-1 .
doi: 10.1007/s00198-017-3919-1
Behre, HM, Kliesch, S, Leifke, E, Link, TM, Nieschlag, E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386–90. https://doi.org/10.1210/jcem.82.8.4163 .
doi: 10.1210/jcem.82.8.4163
Cartwright, B, Robinson, J, Seed, PT, Fogelman, I, Rymer, J. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab 2016;101:3497–505. https://doi.org/10.1210/jc.2015-4063 .
doi: 10.1210/jc.2015-4063
Popat, VB, Calis, KA, Kalantaridou, SN, Vanderhoof, VH, Koziol, D, Troendle, JF, et al.. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab 2014;99:3418–26. https://doi.org/10.1210/jc.2013-4145 .
doi: 10.1210/jc.2013-4145
Zacharin, MR. Puberty, contraception, and hormonal management for young people with disabilities. Clin Pediatr 2009;48:149–55. https://doi.org/10.1177/0009922808324492 .
doi: 10.1177/0009922808324492

Auteurs

Anne Trinh (A)

Monash Health, Clayton, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Angelina Lim (A)

Murdoch Children's Research Institute, Parkville, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Phillip Wong (P)

Hudson Institute of Medical Research, Clayton, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Justin Brown (J)

Monash Health, Clayton, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Janne Pitkin (J)

Murdoch Children's Research Institute, Parkville, VIC, Australia.

Beverley Wollenhoven (B)

Monash Health, Clayton, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Peter Ebeling (P)

Monash Health, Clayton, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Peter Fuller (P)

Hudson Institute of Medical Research, Clayton, VIC, Australia.

Frances Milat (F)

Hudson Institute of Medical Research, Clayton, VIC, Australia.
Monash University, Melbourne, VIC, Australia.

Margaret Zacharin (M)

Murdoch Children's Research Institute, Parkville, VIC, Australia.
Royal Children's Hospital, Melbourne, Australia.

Classifications MeSH